$5 And Under

Osiris Therapeutics Inc. (OSIR) Has Gapped Up Sharply After Q4 Report

Osiris Therapeutics Inc. (OSIR) reported a fourth quarter loss of $0.08 per share Wednesday morning, compared to the profit of $0.15 per share last year. The consensus estimate was for a loss of $0.15.

Osiris Therapeutics has gapped open sharply higher Wednesday and is now up 1.82 at $8.73 on above average volume. The stock has jumped to a month and a half high and has re-crossed its 50-day moving average.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More $5 And Under